Monday Morning Round-Up #4


Welcome to Monday Morning Round-Up, featuring what’s new in health and medicine from around the web!

Air pollution affects preterm birthrates globally, study finds via The Washington Post

A recent study published in the journal Environment International is the first global estimate of preterm births associated with pollution caused by fine particulate matter. The study found that a pregnant woman’s exposure to air pollution has adverse effects on her fetus, with prolonged exposure associated with nearly 1 in 5 premature births globally.

4 latest FDA approvals via Becker’s Hospital Review

Read up on the four latest drugs and medical devices approved by the FDA in the past week, including a diagnostic tool for the identification of sepsis and a new push-button blood collection device.

Facing Pressure, Insurance Plans Loosen Rules For Covering Addiction Treatment via Kaiser Health News

In March, Aetna, one of the nation’s largest insurance companies, will remove a key barrier for patients seeking medication to treat opioid addiction. Specifically, Aetna will stop requiring doctors to seek approval before prescribing particular medications that are used to mitigate withdrawal symptoms, and typically given along with steady counseling. This change will make Aetna the third major insurer to make the switch.

Behind the Clipboard: Adventures of a Lab Inspector via CDC Public Health Matters

Get a backstage look into the life of a Center for Disease Control and Prevention lab inspector. These inspectors are tasked with keeping tabs on some of the nation’s most critical research laboratories – those that are registered to handle many of the world’s deadliest pathogens and poisons, like anthrax, plague, smallpox, and ricin.

Children’s Health uses ingestible sensor to improve adherence in adolescent transplant patients via Mobi Health News

Children’s Health, a system of pediatric hospitals in the Dallas, Texas area, turned to an ingestible sensor when other kinds of remote monitoring weren’t quite getting the job done for a population of post-organ transplant teenagers. The Proteus Discover digital health system uses an ingestible sensor embedded in a pill to record data about – among other things – patients’ medication adherence. The sensor sends data to an adhesive patch, which in turn sends it to a mobile device.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.